Tilray Inc (NASDAQ:TLRY) Shares Acquired by Capstone Investment Advisors LLC

Capstone Investment Advisors LLC lifted its stake in shares of Tilray Inc (NASDAQ:TLRY) by 320.9% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 95,736 shares of the company’s stock after purchasing an additional 72,989 shares during the period. Capstone Investment Advisors LLC’s holdings in Tilray were worth $236,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. SG Americas Securities LLC boosted its holdings in shares of Tilray by 56.7% during the 4th quarter. SG Americas Securities LLC now owns 415,413 shares of the company’s stock worth $955,000 after purchasing an additional 150,247 shares during the last quarter. Public Sector Pension Investment Board boosted its holdings in shares of Tilray by 11.4% during the 3rd quarter. Public Sector Pension Investment Board now owns 1,519,415 shares of the company’s stock worth $3,630,000 after purchasing an additional 155,672 shares during the last quarter. Redhawk Wealth Advisors Inc. acquired a new position in Tilray in the fourth quarter valued at approximately $38,000. Banque Pictet & Cie SA acquired a new position in Tilray in the third quarter valued at approximately $84,000. Finally, Arizona State Retirement System lifted its holdings in Tilray by 8.2% in the fourth quarter. Arizona State Retirement System now owns 204,148 shares of the company’s stock valued at $470,000 after acquiring an additional 15,449 shares during the last quarter. 9.35% of the stock is currently owned by institutional investors and hedge funds.

Tilray Stock Up 4.0 %

Tilray stock opened at $1.83 on Thursday. Tilray Inc has a twelve month low of $1.60 and a twelve month high of $3.40. The stock’s fifty day simple moving average is $1.82 and its 200-day simple moving average is $1.93. The company has a current ratio of 1.92, a quick ratio of 1.18 and a debt-to-equity ratio of 0.11. The firm has a market capitalization of $1.42 billion, a P/E ratio of -4.16 and a beta of 2.19.

Analyst Ratings Changes

A number of research analysts recently commented on TLRY shares. CIBC decreased their price objective on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a report on Wednesday, April 10th. Alliance Global Partners upped their price objective on Tilray from $2.25 to $2.75 and gave the company a “neutral” rating in a report on Friday, April 5th. Finally, Canaccord Genuity Group decreased their price objective on Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.